LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression

BACKGROUND: Anti-angiogenic therapy represents a promising strategy for non-small-cell lung cancer (NSCLC) but its application in lung squamous cell carcinoma (SQC) is limited due to the high-risk adverse effects. Accumulating evidence indicates that long noncoding RNAs (lncRNAs) mediate in tumor pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiarong, Liu, Aibin, Wang, Zhihui, Wang, Bin, Chai, Xingxing, Lu, Wenjie, Cao, Ting, Li, Ronggang, Wu, Minyan, Lu, Zhuming, Pang, Wenguang, Xiao, Lin, Chen, Xiangmeng, Zheng, Yan, Chen, Qiong, Zeng, Jincheng, Li, Jun, Zhang, Xin, Ren, Dong, Huang, Yanming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260858/
https://www.ncbi.nlm.nih.gov/pubmed/32473645
http://dx.doi.org/10.1186/s12943-020-01217-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260858/
https://www.ncbi.nlm.nih.gov/pubmed/32473645
http://dx.doi.org/10.1186/s12943-020-01217-2

Ejemplares similares